X
 
Based in Malaysia, Bioven is an international company with offices in Kuala Lumpur and London.
 
OUR STORY OUR TEAM
BOARD OF DIRECTORS
Tan Sri Dato' Dr. Abu Bakar Suleiman
Chairman

A consultant nephrologist, Dr Abu Bakar was previously the Director-General of the MoH, Malaysia and appointed as the President of a leading private university, International Medical University (IMU), in 1991. in 2011, Dr Abu Bakar brings a wealth of experience and knowledge in Public Healthcare as well as a commercial healthcare provider. He was appointed Chairman of Integrated Healthcare Holdings Ltd (IHH), the 2nd largest private healthcare group in the world, in 2011.

Dr Abu Bakar has been Bioven’s Chairman since 2009.

Johan Indot
Executive Deputy Chairman

Johan is the founder and major shareholder in Bioven, incorporated in 2002. Johan is an entrepreneur and has developed many start up companies that have eventually been sold on. He currently has investment interest in Oil and Gas and Finance and took on an active role in Bioven in 2006.

Johan has worked closely with the management team to develop Bioven’s assets.

Ooi Pang Kok
Director

Ooi Pang Kok is the Chief Financial Officer / Executive Vice President, Strategic Investment & Innovation Skills Agensi Inovasi Malaysia (AIM).

He started off his career in PricewaterhouseCoopers in the audit and assurance division. He continued his career in several public listed companies handling all matters pertaining to Financial Reporting Standards, Bursa listing Requirements and all other new requirements, reviewing and implementing control systems, budgetary planning, cost management and cash flow, tax planning, corporate business planning, corporate financing and project financing amongst others. Pang Kok assume his current role at AIM in 2013 overseeing the Corporate Services Division which encompasses Finance, Legal, IT, Procurement and Administration. In 2018, he was tasked to oversee the Strategic Investment and Innovation Skills Division, handling and managing the overall investments or initiatives for both Divisions.

Pang Kok graduated with a Bachelor of Accountancy from University of South Australia, Adelaide and is a member of CPA Australia and Malaysian Institute of Accountants.

He joined the Board in June 2018

Wong Mun Keong
Director

Mun Keong was the General Manager, Business Development and Corporate Finance, at a Malaysian listed group in property and infrastructure development. Mun Keong is a former lecturer in finance at the University of Technology, Sydney, and headed the KL office of Schroder Research (Malaysia). He is currently Chief Investment Officer at Private Investment Company, managing over USD200m in assets with investments in property development, manufacturing and mining.

MANAGEMENT TEAM
Johan Indot
Executive Deputy Chairman

Johan is the founder and major shareholder in Bioven, incorporated in 2002. Johan is an entrepreneur and has developed many start up companies that have eventually been sold on. He currently has investment interest in Oil and Gas and Finance and took on an active role in Bioven in 2006.

Johan has worked closely with the management team to develop Bioven’s assets.

Dr Erik D’Hondt
CSO

Erik D’Hondt joined Bioven in 2009 as Head of R&D and Regulatory. Erik is a highly experienced drug development executive who worked for 28 years at SmithKline Beecham (now GlaxoSmithKline) in biologicals research and regulatory roles. More recently, Erik was Vice-President of Therapeutics at Europe’s Innogenetics (now Fujirebio Europe) and he has also consulted widely in Asia for institutes and biotechnology companies. He was an adviser to the World Health Organisation on preparedness for pandemic influenza.

Thomas Thevenet
Head of Clinical Development

A qualified pharmacist, Thomas has over 10 years in clinical development. Thomas has experience in diagnostic and therapeutic radiopharmaceuticals in oncology, rheumatology, neurology, cardiovascular and inflammatory diseases.

Dr Lesley Pillans
Medical Liaison & Eudravigilence

Lesley is a Special Grade Doctor in Eating Disorders and practises in Aberdeen, Scotland. Prior to joining Bioven as Head of Medical Liaison, where she is responsible for Eudravigilence, medical affairs and communications, Lesley had worked as Medical Advisor for Shell International BV at the Hague. She has also worked in Malaysia as a Clinical Research Officer at University Malaya Medical Centre in Kuala Lumpur.

Shirley Chong
Financial Controller

Shirley graduated with a Bachelor of Accounting (Hons) from Multimedia University Cyberjaya. Started her career with KPMG as Tax Consultant for 6 years. She then moved to the commercial from various industries ( IT, Training and healthcare supplies and trading) as Finance Manager. She joined Bioven in April 2016 as Financial Controller.